FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 9.3%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 1,466,507 | $6,217,990 | 9.26% |
External links
This page lists FREELINE THERAPEUTICS HLDGS's shareholders in Q3 2023. To view FREELINE THERAPEUTICS HLDGS's shareholder history, click here.